Toby Michael Maher

Professional History 2020 - Professor of Medicine and Director of ILD, University of Southern California 2018 - 2020 Director, NIHR Royal Brompton Respiratory Clinical Research Facility 2018 - 2020 Director of Respiratory Research, Royal Brompton Hospital 2017 - Professor of Interstitial Lung Disease, Imperial College London 2017 - British Lung Foundation Chair in Respiratory Research 2015 - 2017 Senior Lecturer, Imperial College, London 2014 - 2019 NIHR Clinician Scientist, Royal Brompton Hospital 2010 - 2015 Honorary Senior Lecturer, Imperial College, London 2009- 2015 Honorary Senior Lecturer, University College London 2009 - 2022 Consultant Physician, Royal Brompton Hospital 2006 – 2009 Wellcome Trust Clinical Research Fellow, UCL Clinical Trials In the last 10 years I have been the local Principal Investigator on over 50 clinical trials in interstitial lung disease ranging from Phase 1 to Phase 4 and have enrolled over 1500 subjects in to studies. These include trials in IPF (>30), sarcoidosis (1), scleroderma (5), myositis (1), LAM (1) and Rheumatoid arthritis (1). I am currently Global Chief Investigator of 4 Phase 1b, 3 Phase 2 and 3 phase 3 clinical trials. I serve or have served on 8 Trial Steering Committees, 10 Data Safety Monitoring Committees and 5 endpoint adjudication committees. I am Chief Investigator of the NIHR EME funded RECITAL study and am on the Trial Steering Committee of the NIHR EME funded TIPAC trial.